Elite Pharmaceuticals Inc /NV/ SEC filings ELTP
Elite Pharmaceuticals Inc /NV/ has 1,000 filings in SEC EDGAR's recent list, going back to Apr 5, 2005. Its latest annual report, Form 10-K, was filed on Jun 29, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jul 1, 2024 | — |
| S-8 | Employee stock plan registration | Mar 28, 2024 | — |
| S-8 | Employee stock plan registration | Mar 28, 2024 | — |
| 424B3 | Prospectus | Jul 27, 2020 | — |
| S-3 | Shelf registration | Jul 15, 2020 | — |
| 424B3 | Prospectus | Jun 5, 2017 | — |
| S-3/A | Form s-3/a | Jun 2, 2017 | — |
| S-3 | Shelf registration | May 10, 2017 | — |
| 424B3 | Prospectus | Feb 9, 2017 | — |
| 424B3 | Prospectus | Nov 9, 2016 | — |
| 424B3 | Prospectus | Aug 9, 2016 | — |
| 424B3 | Prospectus | Jul 21, 2016 | — |
| 424B3 | Prospectus | Jul 15, 2016 | — |
| 424B3 | Prospectus | Jul 14, 2016 | — |
| S-1 | Registration statement | Jun 27, 2016 | — |
| S-8 | Employee stock plan registration | Jul 29, 2014 | — |
| 424B3 | Prospectus | Jul 8, 2014 | — |
| POS AM | Filing | Jul 1, 2014 | — |
| 424B3 | Prospectus | May 5, 2014 | — |
| S-1/A | Amended registration statement | May 1, 2014 | — |
| S-1/A | Amended registration statement | Apr 28, 2014 | — |
| S-3 | Shelf registration | Apr 15, 2014 | — |
| 424B3 | Prospectus | Mar 18, 2014 | — |
| 424B3 | Prospectus | Feb 18, 2014 | — |
| 424B3 | Prospectus | Nov 15, 2013 | — |
| 424B3 | Prospectus | Aug 14, 2013 | — |
| 424B3 | Prospectus | Aug 5, 2013 | — |
| 424B3 | Prospectus | Jun 27, 2013 | — |
| POS AM | Filing | Jun 25, 2013 | — |
| 424B3 | Prospectus | May 10, 2013 | — |
| S-1 | Registration statement | Apr 25, 2013 | — |
| S-1 | Registration statement | Mar 1, 2012 | — |
| S-8 | Employee stock plan registration | Dec 22, 2009 | — |
| 424B3 | Prospectus | Jan 31, 2008 | — |
| S-3/A | Filing | Jan 14, 2008 | — |
| S-3/A | Filing | Jan 2, 2008 | — |
| S-3 | Shelf registration | Aug 16, 2007 | — |
| 424B3 | Prospectus | Jul 13, 2007 | — |
| 424B3 | Prospectus | Jul 13, 2007 | — |
| S-3 | Shelf registration | Jun 1, 2007 | — |
| S-3 | Shelf registration | May 24, 2007 | — |
| 424B1 | Filing | Apr 26, 2006 | — |
| 424B1 | Filing | Apr 26, 2006 | — |
| S-3 | Shelf registration | Apr 14, 2006 | — |
| S-3 | Shelf registration | Apr 13, 2006 | — |
| S-8 | Employee stock plan registration | Mar 1, 2006 | — |
| S-1 | Registration statement | Apr 27, 2005 | — |
Showing 47 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ELTP (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- NJ
- Headquarters
- Northvale, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1053369
- Former names
- ELITE PHARMACEUTICALS INC /DE/ (until Feb 8, 2012)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.